1. Home
  2. LVTX

LVTX

LAVA Therapeutics N.V.

Logo LAVA Therapeutics N.V.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

Founded: 2016 Country:
Netherlands
Netherlands
Employees: N/A City: N/A
Market Cap: 82.3M IPO Year: 2021
Target Price: $6.00 AVG Volume (30 days): 1.8M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.67 EPS Growth: N/A
52 Week Low/High: $1.13 - $6.47 Next Earning Date: 06-06-2024
Revenue: $7,521,111 Revenue Growth: -65.09%
Revenue Growth (this year): 5.48% Revenue Growth (next year): N/A

Share on Social Networks: